𝔖 Bobbio Scriptorium
✦   LIBER   ✦

OP33. Determining the importance of specific symptoms for the economic evaluation of advanced prostate cancer therapies

✍ Scribed by KR Yabroff; I Barofsky; A Pearson; M Rothman

Book ID
118606652
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
166 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Can prostate-specific antigen be used as
Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer?
✍ B. Seckin; C. T. Anthony; B. Murphy; M. S. Steiner πŸ“‚ Article πŸ“… 1996 πŸ› Springer-Verlag 🌐 English βš– 444 KB

It is current practice in many clinical trials evaluating new chemotherapy regimens for the treatment of advanced prostate cancer to use prostate-specific antigen (PSA) decline as a response criteria with the assumption that the level of PSA reflects the efficacy of chemotherapy. Advanced prostate c